Article Details
Retrieved on: 2018-01-07 17:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. boosted its position in shares of Kite Pharma by 9.2% in the second quarter. <b>Vanguard Group</b> Inc. now owns 3,998,269 shares of the biopharmaceutical company's stock worth $414,501,000 after purchasing an additional 336,722 shares during the period. Prudential Financial Inc.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here